_shontel-brown-praises-fda-head-for-investigating-link-between-chemical-hair-straighteners-amp-cancer.jpg "Shontel Brown Praises FDA Head For Investigating Link Between Chemical Hair Straighteners & Cancer from itas login fda Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 5:37
👁 View: 205K times
✓ Published: 02-May-2024
👁 View: 205K times
✓ Published: 02-May-2024
Description:
At a House Oversight Committee hearing earlier this month, Rep. Shontel Brown (D-OH) spoke to FDA Commissioner Robert Califf about the health risks of chemical hair straighteners, OTC birth control and diabetes.<br/><br/>Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more:<br/><br/>https://account.forbes.com/membership/?utm_source=youtube&utm_medium=display&utm_campaign=growth_non-sub_paid_subscribe_ytdescript<br/><br/><br/>Stay Connected<br/>Forbes on Facebook: http://fb.com/forbes<br/>Forbes Video on Twitter: http://www.twitter.com/forbes<br/>Forbes Video on Instagram: http://instagram.com/forbes<br/>More From Forbes:http://forbes.com
At a House Oversight Committee hearing earlier this month, Rep. Shontel Brown (D-OH) spoke to FDA Commissioner Robert Califf about the health risks of chemical hair straighteners, OTC birth control and diabetes.<br/><br/>Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more:<br/><br/>https://account.forbes.com/membership/?utm_source=youtube&utm_medium=display&utm_campaign=growth_non-sub_paid_subscribe_ytdescript<br/><br/><br/>Stay Connected<br/>Forbes on Facebook: http://fb.com/forbes<br/>Forbes Video on Twitter: http://www.twitter.com/forbes<br/>Forbes Video on Instagram: http://instagram.com/forbes<br/>More From Forbes:http://forbes.com
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_e-coli-outbreak-linked-to-organic-walnuts-under-investigation.webp "The CDC and FDA are investigating an E. coli outbreak associated with organic walnuts sold in food co-ops and natural food stores. With 12 reported cases and seven hospitalizations in California and Washington, concerns are rising. Veuer’s Maria Mercedes Galuppo has the story.")
_fast-fda-faq-how-to-register-with-fda.webp "FDAImports.com, LLC")
_introduction-to-the-fda-office-of-training-education-and-developments-train-the-trainer-program.webp "U.S. Food and Drug Administration")
⏲ 4 minutes 38 seconds 👁 1K
_state-fda-pharmaceutical-regulation.webp "THIRD-IP Channel")
_u-s-fda-food-facility-registration.webp "Registrar Corp")
_dea39s-move-to-reclassify-cannabis-seen-as-39significant39-but-fails-to-resolve-state-federal-conflict.webp "The DEA's decision to move cannabis from Schedule I to Schedule III is the first time the agency has called for rescheduling botanical cannabis under federal law. This comes after the HHS requested changes to cannabis' Schedule I classification eight months ago. Organization for the Reform of Marijuana Laws's deputy director called it significant for federal agencies to acknowledge cannabis' therapeutic benefits and safety. However, rescheduling to Schedule III would not resolve the conflict between state cannabis laws and federal regulations. Schedule III substances require FDA approval and prescriptions from licensed pharmacies.")
DEA's Move To Reclassify Cannabis Seen As 'Significant,' But Fails To Resolve State-Federal Conflict
⏲ 0:38 👁 835K
_fda-review-and-approval-process-for-biosimilar-medications.webp "U.S. Food and Drug Administration")
_e-coli-outbreak-linked-to-organic-walnuts-under-investigation.jpg)
_fast-fda-faq-how-to-register-with-fda.jpg)
_introduction-to-the-fda-office-of-training-education-and-developments-train-the-trainer-program.jpg)
_state-fda-pharmaceutical-regulation.jpg)
_u-s-fda-food-facility-registration.jpg)
_dea39s-move-to-reclassify-cannabis-seen-as-39significant39-but-fails-to-resolve-state-federal-conflict.jpg)
_fda-review-and-approval-process-for-biosimilar-medications.jpg)
![[+]](/images/menu.gif){kind=small}